Collectively, these findings indicate that beauvericin modulates multiple malignant phenotypes of CRC cells <i>in vitro</i> by inducing mitochondrial apoptosis and attenuating EMT-associated signaling, VEGF-dependent endothelial activation, and JAK/STAT pathway activity. This evidence concerns the gene VEGFA and colorectal carcinoma.